Igraine Plc - Audited Results to 31 December 2020 : vimarsana.com

Igraine Plc - Audited Results to 31 December 2020

Igraine Plc - Audited Results to 31 December 2020 PR Newswire London, December 22 IGRAINE PLC AQSE: KING ("Igraine" or the "Company") Audited Final Results

Related Keywords

United Kingdom , Zurich , Züsz , Switzerland , Camborne , Cornwall , United States , London , City Of , American , Swiss , John Martin , Chris Evans , Martin Walton , Ramsay Smith , Miller Mark Anwyl , Burns Singh Tennent Bhohi , Arix Bioscience , Stephen Winfield , Simon Grant , Brian Jones , Stephen Steve David Winfield , Christopher Evans , Kenneth Hillen , Directors Of Igraine , Rio Tinto , Simbec Orion Group , Market Of The London Stock Exchange , Exchange Growth Market , Astrazeneca , Facebook , X Markets Group Limited , Excalibur Healthcare Services , Shareholders The Company , Board Of Igraine , Merlin Biosciences Ltd , Iota Sciences Ltd , Group United Kingdom , Excalibur Medicines Ltd , Rapid Nutrition Plc , Just Bee Drinks Limited , Ellipses Pharma , Excalibur Healthcare Services Ltd , Glenpani Group , Bradshaw Consulting Ltd , Directors Of The Company , Twitter , Excalibur Fund Managers Life Sciences , Excalibur Group , Arthurian Life Sciences Ltd , Merlin Ventures , Asset Capital Ltd , Peterhouse Capital , Oxford University , Globe Capital Ltd , Economics Social Sciences , Chiroscience , Wales Life Sciences Investment Fund , Sosei Co , Igraine Plc , University Of Glasgow , Swiss Exchange , Biotech Growth , Media House International , Camborne School Of Mines Bsc Mining Engineering , Biovex Group Inc , Piramed Limited To Roche Group , Amgen Inc , Just Bee Drinks Ltd , Forum Energy Metals Corp , Final Results , Access Segment , Growth Market , Non Executive Chairman , London Stock Exchange , Directors Post Year End Review , Following Meetings , Apple Wallet , Google Pay , Wallet Ads , One Media , Just Bee , Just Bee Drinks , Year Ending , Annual General Meeting , General Meeting , Peterhouse Capital Limited , Corporate Advisor , Professor Christopher Evans , Sir Christopher Evans , Merlin Biosciences Funds , Biovex Group , Piramed Limited , Through Merlin Ventures Limited , Biotech Growth Trust , Merlin Biosciences , Ellipses Pharma Limited , Professor Sir Christopher Evans , Scoffs Group , Costa Coffee , Strategic Advisory , Interrad Medical , Minneapolis Based Medtech , Vice Chairman , Executive Chairman , Professor Sir Chris Evans , Excalibur Fund Managers , Life Sciences , Singh Tennent Bhohi , Forum Energy Metals , Janice Lake , North American , Camborne School , Mining Engineering , Falconbridge Internationals , Management Roles , All Active Asset Capital Ltd , Globe Capital , Quetzal Capital , New Investment , Co Investment Agreement , Executive Team , Investigational New Drug , New Drug Applications , Co Investment Rights , Excalibur Healthcare , Deferred Shares , These Deferred Shares , Potential Therapy , George Street Capital , United Kingdom Based , Serious Adverse Events , Treatment Emergent Adverse Events , Excalibur Medicines , Sir Chris , Professor John Martin , Executive Director , Market Corporate , Media House , Igraine , Udited , Esults , Ecember , 020 ,

© 2024 Vimarsana